In late 2021, Flow Integrative was selected as the Credentialed Provider for Dr. Bronner’s Magic Soap Company, becoming the first clinic to offer fully covered ketamine infusion therapy via the third-party benefits administrator, Enthea.
This pilot offered more than just insurance-backed access. It opened the door to something rare in psychedelic care: a diverse range of psychological profiles, cultural backgrounds, and lived experiences
This real-world pilot allowed Flow to develop and validate clinical protocols at a scale and diversity unmatched in typical psychedelic settings. What emerged was
a deeply ethical, robust, and adaptive framework—one that now forms the foundation of Flow’s licensing model.
Launching a ketamine infusion therapy program at scale—within a real-world workforce—posed meaningful complexities:
Key challenges included:
Flow’s task was to prove that psychedelic therapy could be democratized—without compromising outcomes.
While many providers rely on generic dosing models, Flow had the opportunity to evolve its methodology over the course of three years. With exposure to real-world variation—across demographics, psychographics, and pharmacological histories—Flow was able to:
This pilot didn’t just validate Flow’s model. It forged it.
The protocol tested here became the foundation for what is now offered to clinics nationwide—a time-tested, ethically sound, and dynamically structured approach that works in the real world.
The outcomes below reflect just one year of service—within a three-year operational span. Even in that first year, Flow demonstrated not only strong clinical impact but also operational excellence and scalability.
Clinical Outcomes:
Operational Success:
“These findings hold significant weight, especially considering that a substantial percentage of patients do not respond to antidepressants, and talk therapy proves effective for only about 40% of individuals… Flow Integrative, Enthea’s flagship Credentialed Provider in San Diego, delivered all treatments under the Dr. Bronner’s-sponsored benefit.”
“The results speak for themselves and demonstrate the unique effectiveness of ketamine-assisted therapy.”
— Dr. Dan Rome, Chief Medical Officer, Enthea
”My very first session opened my eyes to a new kind of reality that I had more control in and could find safety in. The consistent and ongoing (boosters) ketamine treatments and integrations have lifted me out of the darkest depression, saved me from suicidal ideation, and given me new perspective, new hope, new tools, and new motivation to use those tools. By removing fears of the unknown and relieving me of everyday anxieties. I no longer feel doomed.”
– Dr. Bronner’s Employee
If you're looking to offer ketamine therapy but lack the systems or support—Flow has already done the work. Start your journey with the model that’s already changing lives.
Explore how clinics like yours are transforming patient care with Flow’s Adaptive Ketamine Therapy™ model.
